HCA Healthcare Inc.

NYSE: HCA · Real-Time Price · USD
395.42
1.77 (0.45%)
At close: Aug 15, 2025, 3:42 PM

HCA Healthcare Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
18.61B 18.32B 18.29B 17.49B 17.49B 17.34B 17.3B 16.21B 15.86B 15.59B 15.5B 14.97B 14.82B 14.95B 15.06B 15.28B 14.44B 13.98B
Cost of Revenue
15.64B 15.47B 15.44B 15.08B 14.76B 14.78B 14.5B 14.12B 13.56B 13.16B 13.08B 12.83B 12.52B 12.74B 12.68B 12.8B 11.95B 11.64B
Gross Profit
2.97B 2.85B 2.85B 2.41B 2.73B 2.56B 2.8B 2.09B 2.3B 2.43B 2.41B 2.14B 2.3B 2.2B 2.39B 2.47B 2.48B 2.33B
Operating Income
2.97B 2.85B 2.85B 2.41B 2.73B 2.56B 2.8B 2.09B 2.3B 2.43B 2.41B 2.14B 2.3B 2.2B 2.39B 2.47B 2.48B 2.33B
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
2.42B 2.33B 2.13B 1.91B 2.24B 2.25B 2.35B 1.63B 1.81B 1.92B 3.3B 1.7B 1.76B 1.81B 2.59B 3.16B 2.12B 1.97B
Net Income
1.65B 1.61B 1.44B 1.27B 1.46B 1.59B 1.61B 1.08B 1.19B 1.36B 2.08B 1.13B 1.16B 1.27B 1.81B 2.27B 1.45B 1.42B
Selling & General & Admin
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Interest Expense
568M 547M 528M 515M 506M 512M 491M 483M 485M 479M 455M 446M 432M 406M 389M 388M 377M 393M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
15.64B 15.47B 15.44B 15.08B 14.76B 14.78B 14.5B 14.12B 13.56B 13.16B 13.08B 12.83B 12.52B 12.74B 12.68B 12.8B 11.95B 11.64B
Income Tax Expense
524M 502M 447M 424M 550M 445M 484M 355M 397M 379M 656M 360M 381M 349M 581M 685M 453M 393M
Shares Outstanding (Basic)
241.91M 249.44M 252.3M 259.92M 263.22M 263.22M 265.54M 271.17M 274.49M 276.91M 277.38M 285.96M 292.53M 302.45M 305.48M 318.07M 328.17M 338.12M
Shares Outstanding (Diluted)
241.91M 249.44M 255.31M 259.92M 264.07M 268.02M 271.19M 275.42M 278.2M 280.96M 285.66M 289.85M 296.06M 307.37M 315.42M 324.03M 332.61M 343.32M
EPS (Basic)
7.00 6.52 5.70 4.94 5.60 6.04 6.05 3.98 4.35 4.92 7.50 3.97 3.95 4.21 5.94 7.13 4.42 4.21
EPS (Diluted)
6.83 6.45 5.63 4.89 5.53 5.94 5.93 3.92 4.29 4.85 7.28 3.91 3.90 4.14 5.75 7.00 4.36 4.14
EBITDA
3.85B 3.73B 3.52B 3.26B 3.56B 3.55B 3.63B 2.88B 3.06B 3.16B 4.51B 2.9B 2.93B 2.95B 3.7B 4.26B 3.21B 3.06B
EBIT
2.98B 2.87B 2.66B 2.42B 2.74B 2.76B 2.84B 2.11B 2.29B 2.4B 3.76B 2.15B 2.19B 2.22B 2.98B 3.54B 2.49B 2.37B
Depreciation & Amortization
863M 860M 856M 842M 819M 795M 789M 769M 763M 756M 750M 749M 738M 732M 728M 716M 712M 697M